Screening FMT donors during the COVID-19 pandemic: a protocol for stool SARS-CoV-2 viral quantification.
作者信息
Ng Siew C, Chan Francis K L, Chan Paul K S
机构信息
Center for Gut Microbiota Research, The Chinese University of Hong Kong, Hong Kong.
Center for Gut Microbiota Research, The Chinese University of Hong Kong, Hong Kong.
出版信息
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):642-643. doi: 10.1016/S2468-1253(20)30124-2. Epub 2020 Apr 22.
Abstract
摘要
相似文献
1
Screening FMT donors during the COVID-19 pandemic: a protocol for stool SARS-CoV-2 viral quantification.在2019冠状病毒病大流行期间筛查粪菌移植供体：粪便严重急性呼吸综合征冠状病毒2病毒定量方案
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):642-643. doi: 10.1016/S2468-1253(20)30124-2. Epub 2020 Apr 22.
2
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward.通过对粪便进行分子检测来筛查严重急性呼吸综合征冠状病毒2（SARS-CoV-2）粪便微生物群移植供体是最安全的前进方式。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):531. doi: 10.1016/S2468-1253(20)30089-3. Epub 2020 Mar 30.
3
[Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].[鉴于新型冠状病毒大流行重新审视粪便微生物群移植的技术方面和质量管理背景]
Orv Hetil. 2020 Nov 1;161(44):1858-1871. doi: 10.1556/650.2020.32023.
4
Hospital-at-Home as an Alternative to Release the Overload of Healthcare Systems During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic.在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行期间，居家医院作为一种替代方案来缓解医疗系统的负担。
J Am Med Dir Assoc. 2020 Jul;21(7):990-991. doi: 10.1016/j.jamda.2020.04.024. Epub 2020 May 3.
5
Risk of SARS-CoV-2 Diffusion when Performing Minimally Invasive Surgery During the COVID-19 Pandemic.在新冠疫情期间进行微创手术时SARS-CoV-2传播的风险
Eur Urol. 2020 Jul;78(1):e12-e13. doi: 10.1016/j.eururo.2020.04.015. Epub 2020 Apr 13.
6
Re: Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and 'suppressing' the pandemic.关于：对计划进行手术的新冠肺炎（严重急性呼吸综合征冠状病毒2）患者的检测建议——持续提供服务并“遏制”疫情。
Br J Oral Maxillofac Surg. 2020 Jul;58(6):733. doi: 10.1016/j.bjoms.2020.05.012. Epub 2020 May 16.
7
SARS-COV-2 pandemic: the significance of underlying conditions.严重急性呼吸综合征冠状病毒2型大流行：基础疾病的重要性。
Occup Med (Lond). 2020 Jul 17;70(5):352-353. doi: 10.1093/occmed/kqaa084.
8
The impacts of the novel SARS-CoV-2 outbreak on surgical oncology - A letter to the editor on "The socio-economic implications of the coronavirus and COVID-19 pandemic: A review".新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫情对外科肿瘤学的影响——致编辑的一封信，主题为“冠状病毒及2019冠状病毒病大流行的社会经济影响：综述”
Int J Surg. 2020 Jul;79:109-110. doi: 10.1016/j.ijsu.2020.05.032. Epub 2020 May 19.
9
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).无症状冠状病毒感染：中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2（新型冠状病毒肺炎）
Travel Med Infect Dis. 2020 May-Jun;35:101608. doi: 10.1016/j.tmaid.2020.101608. Epub 2020 Feb 27.
10
Pangolins Harbor SARS-CoV-2-Related Coronaviruses.穿山甲携带 SARS-CoV-2 相关冠状病毒。
Trends Microbiol. 2020 Jul;28(7):515-517. doi: 10.1016/j.tim.2020.04.001. Epub 2020 Apr 6.
引用本文的文献
1
Assuring safety of fecal microbiota transplantation in the COVID-19 era: A single-center experience.确保新冠肺炎疫情时代粪便微生物群移植的安全性：单中心经验
JGH Open. 2023 Oct 20;7(11):765-771. doi: 10.1002/jgh3.12979. eCollection 2023 Nov.
2
Molecular Diagnosis of COVID-19; Biosafety and Pre-analytical Recommendations.新型冠状病毒肺炎的分子诊断；生物安全与分析前建议
Iran J Pathol. 2023 Summer;18(3):244-256. doi: 10.30699/IJP.2023.1988405.3061. Epub 2023 Jul 16.
3
Rapid RT-PCR identification of SARS-CoV-2 in screening donors of fecal microbiota transplantation.在粪便微生物群移植筛查供体中对严重急性呼吸综合征冠状病毒2进行快速逆转录聚合酶链反应鉴定
Heliyon. 2023 Jun;9(6):e17438. doi: 10.1016/j.heliyon.2023.e17438. Epub 2023 Jun 18.
4
A study of the correlation between stroke and gut microbiota over the last 20years: a bibliometric analysis.过去20年中风与肠道微生物群相关性的研究：一项文献计量分析。
Front Microbiol. 2023 Jun 7;14:1191758. doi: 10.3389/fmicb.2023.1191758. eCollection 2023.
5
The Inhibition and Variability of Two Different RT-qPCR Assays Used for Quantifying SARS-CoV-2 RNA in Wastewater.两种不同 RT-qPCR assays 用于定量污水中 SARS-CoV-2 RNA 的抑制和变异性。
Food Environ Virol. 2023 Mar;15(1):71-81. doi: 10.1007/s12560-022-09542-z. Epub 2023 Feb 15.
6
Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy.粪菌移植治疗溃疡性结肠炎：一种不断发展的疗法。
Crohns Colitis 360. 2020 Aug 15;2(4):otaa067. doi: 10.1093/crocol/otaa067. eCollection 2020 Oct.
7
Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.粪便微生物群移植在治疗胃肠和代谢疾病中的应用和发展：综述。
Saudi J Gastroenterol. 2023 Jan-Feb;29(1):3-11. doi: 10.4103/sjg.sjg_131_22.
8
Promises of microbiome-based therapies.基于微生物组的治疗方法的承诺。
J Hepatol. 2022 Jun;76(6):1379-1391. doi: 10.1016/j.jhep.2021.12.003.
9
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation.两种用于粪便微生物群移植粪便供体中 SARS-CoV-2 检测的商业多重实时荧光定量 PCR 检测方法的验证
Microorganisms. 2022 Jan 26;10(2):284. doi: 10.3390/microorganisms10020284.
10
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.肠道微生物组在人类神经疾病中的作用的综合综述。
Clin Microbiol Rev. 2022 Jan 19;35(1):e0033820. doi: 10.1128/CMR.00338-20. Epub 2022 Jan 5.
本文引用的文献
1
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward.通过对粪便进行分子检测来筛查严重急性呼吸综合征冠状病毒2（SARS-CoV-2）粪便微生物群移植供体是最安全的前进方式。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):531. doi: 10.1016/S2468-1253(20)30089-3. Epub 2020 Mar 30.
2
Virological assessment of hospitalized patients with COVID-2019.住院 COVID-19 患者的病毒学评估。
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.
3
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
4
Drug-Resistant Bacteremia Transmitted by Fecal Microbiota Transplant.耐药菌血症通过粪便微生物群移植传播。
N Engl J Med. 2019 Nov 21;381(21):2043-2050. doi: 10.1056/NEJMoa1910437. Epub 2019 Oct 30.
Zotero 插件